Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Possis Medical gets $17 million financing:

This article was originally published in Clinica

Executive Summary

Possis Medical has secured a financing commitment for up to $17 million from a group of institutional investors. The Minneapolis-based company will use the proceeds for research and development into applications for its AngioJet Rheolytic Thrombectomy system - which is sold in the US for the treatment of dialysis access graft thrombosis - as well as expanding its sales and marketing operations. The company says the AngioJet system can be used to quickly remove blood clots from vessels. It has been designed to treat a range of conditions, including heart attacks, stroke, dialysis access failure, pulmonary embolism and deep vein thrombosis.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts